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Experimental Section
General. All starting materials were commercial substances. LR grade solvents and commercial reagents were used without further purification. The FT IR spectra were recorded as KBr pallet and only diagnostic and/or intense peaks are reported. Mass spectra (70 eV) were recorded on LC-MS spectrometer. The melting points were determined by using the capillary method and are uncorrected.
1 HNMR spectra were recorded in CDCl 3 and DMSO-d6 using a 400 MHz instrument. 13 C NMR spectra were recorded in CDCl 3 and DMSO-d6 using a 400 MHz instrument. Signals due to the solvent ( 13 C NMR) or residual protonated solvent ( 1 H NMR) served as the internal standard. The 1 H NMR chemical shifts and coupling constants were determined assuming first-order behavior. Multiplicity is indicated by one or more of the following: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad); the list of coupling constants (J) corresponds to the order of multiplicity assignment. TLC analyses were performed on silica gel precoated-plates (250 µm layers). We note that our stereo chemical assignments are supported by comparisons with the literature. HPLC analysis was performed with Waters Symmetry shield RP18 (250X4.6 mm, 5µ) column by using gradient elution and monitored at 220 nm.
Preparation of (R)-ethyl 2-(2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)-N-methyl propanamido)acetate (11).
A mixture of N-Boc-D-tryptophan (5 g, 16.4 mmol) and THF (25 mL) was cooled to -20 °C under nitrogen atmosphere. To the mixture charged N-methyl morpholine (1.83 g, 18 mmol) and stirred for 20 min. Thereafter, a solution of ethyl chloroformate (1.95 g, 18 mmol) in THF (2 mL) was slowly added and stirred the reaction mass for 30 min. Subsequently, a solution of sarcosine ethyl ester in THF (5 mL) was prepared by treating sarcosine ethyl ester hydrochloride (2.76 g, 18 mmol) with N-methyl morpholine (2 g). This solution was added to the solution of mixed anhydride in THF drop wise at -20 °C. The reaction mass was allowed to attain ambient temperature and maintained for 1 h. After completion of the reaction, solvent was removed by distillation (CAUTION: THF forms peroxides while distillation and hence PPE should be wear during concentration of THF) and to the obtained residue water and DCM were charged. After stirring, organic layer was separated and 2N HCl washings (2 X 10 mL) were given followed by bicarbonate washing (1X10 mL). 24.9, 25.6, 28.3, 29.3, 33.9, 36.2, 49.6, 50.8, 51.0, 61.2, 77.6, 110.2, 111.1, 118.7, 119.5, 121.9, 123.3, 136.0, 155.2, 168.9, 172.8; IR (KBr) ν 3295, 3060, 2981 , 2933 , 1750 , 1688 , 1645 , 1459 , 1203 , 1171 
(6H,7H)-dione (1c).
A mixture of toluene (10 mL), compound 11 (1 g, 12.4 mmol) and compound 2 (0.36 g, 12.65 mmol) were stirred for 10 min. Trifluoroacetic acid was added slowly and the reaction mass was heated to 45-50 °C, maintained at the same temperature for 15 h and concentrated under vacuum. To the obtained residue, charged water (5 mL) and dichloromethane (5 mL) and the mixture was neutralized with saturated sodium bicarbonate solution. Organic layer was separated and concentrated below 35 °C under vacuum. Charged toluene (5 mL) to the obtained residue and the mixture was heated to reflux. After stirring for 8 h, reaction mass was cooled to ambient temperature and the product separated was filtered to give tadalafil, 1c in 0.39 g, 50% 52.1, 56.2, 56.6, 101.1, 106.4, 107.4, 108.2, 111.2, 118.6, 120.0, 120.6, 122.4, 126.1, 132.8, 135.3, 136.5, 147.1, 147.8, 166.4, 166.8; IR (KBr) ν 3327, 3061, 2904 , 1677 , 1650 , 1627 , 1438 , 1323 , 1242 , 1041 
Preparation of (R)-3-((1H-indol-3-yl) methyl)-1-methyl piperazine-2, 5-dione (15). Method a.
A mixture of compound 11 (2 g, 12.4 mmol) and hydrochloric acid in dioxane (20 mL, 4N) and stirred at ambient temperature for 5 h. Thereafter, reaction mass was concentrated under reduced pressure. Charged DCM and washed with saturated sodium bicarbonate solution (15 mL). Then, solvent was evaporated under reduced pressure to get the desired compound 15 in 0.9 g, 70% yield. Method b. A suspension of HCl salt of compound 3 (1.17 g, 4.58 mmol) in chloroform (10 mL), to that added aqueous ammonia solution (2 mL) and water (10 mL) and stirred at ambient temperature for 10 min. Organic layer was separated and solvent was evaporated under reduced pressure. The obtained residue was diluted with chloroform (10 mL) then added triethyl amine (0.394 g, 3.894 mmol) and cooled to 0 °C. Compound 5 (0.66 g, 5.84 mmol) was added and the reaction mass was stirred for 1 h. Thereafter, water (10 mL) was added to the mass below 10 °C, and organic layer was separated and washed with saturated sodium bicarbonate solution followed by water. Finally, organic layer was distilled under vacuum. To the obtained compound, methylamine (0.42 g, 13.548 mmol) in methanol (10 mL) was added and stirred for 6 h at 55 °C for completion of the reaction. Subsequently, the reaction mass was cooled to ambient temperature and separated solids were filtered. 
(6H,7H)-dione (12). Method a.
A mixture of toluene (10 mL), compound 11 (1 g, 12.4 mmol) and compound 2 (0.36 g, 12.65 mmol) was stirred for 10 min. Trifluoroacetic acid was added slowly and the reaction mass was heated to reflux and maintained at the same temperature for 8 h. Thereafter, the reaction mass was cooled to ambient temperature and neutralize it with saturated sodium bicarbonate solution. Charge dichloromethane (15 mL) to the mass and stir for 10 min. Organic layer was separated and concentrated below 35 °C under vacuum and the product was purified by column chromatography to give pure S,R isomer of tadalafil, 12 in 0.7 g, 65% yield. Method b. A mixture of compound 15 (2 g, 7.78 mmol) and 2 (1.17 g, 7.78 mmol) is taken along with aqueous HCl (10 mL, 6N) and dioxane (10 mL) and stirred at reflux temperature for 1 h. Thereafter, reaction mass was concentrated under reduced pressure. Charged DCM and washed with saturated sodium bicarbonate solution (30 mL). Subsequently, solvent was evaporated under reduced pressure followed by purification through column chromatography using petroleum ethers: ethyl acetate (7:3) to give pure compound 12 in 2.4 g, 80% yield; mp 287-288 °C; purity by HPLC 99.0%; 1 H NMR (400 MHz, CDCl 3 ) δ 2.91-2.98 (m, 1H), 3.0 (s, 3H), 3. 6, 33.4, 51.4, 51.8, 52.4, 101.3, 108.3, 109.0, 119.1, 111.1, 118.4, 120.0, 122.4, 122.7, 126.2, 129.7, 132.3, 136.3, 148.0, 148.1, 161.5, 165.4; IR (KBr) ν 3348, 3060, 2926 , 1657 , 1623 , 1594 , 1452 , 1325 , 1263 , 1040 27.3, 29.7, 33.3, 51.4, 52.2, 53.0, 60.4, 108.7, 111.3, 118.3, 120.0, 122.7, 124.1, 126.2, 127.5, 129.8, 130.3, 131.1, 133.7, 136.3, 136.7, 163 33.3, 51.3, 51.5, 52.3, 55.3, 108.7, 111.1, 114.1, 118.3, 119.8, 122.5, 126.2, 130.0, 130.5, 136.3, 159.8, 161.4, 165.4; IR (KBr) ν 3333, 3057, 2932 , 1658 , 1648 , 1591 , 1459 , 1329 , 1237 , 1126 , 1004 
13
C NMR (100 MHz, CDCl 3 ) δ 27. 6, 33.3, 51.3, 52.3, 52.8, 55.9, 60.5, 105.5, 108.5, 111.2, 118.2, 119.5, 122.3, 126.0, 134.1, 
